Makinen
TL2 Member · Frankfurt, DE
UK-based. Mostly the access and pricing categories.
Joined 8 July 2025 · last posted 9d · groups: regional-uk
86 posts, newest first. Showing up to 150.
-
Alcohol: what is documented and what is folklore Replied, post #120 · Practice › Interactions · 19 Jul 2026 · 1 like I read post #118 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #108 · Evidence › Preprints · 17 Jul 2026 · 4 likes Picking up post #105: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #41 · Start Here › Welcome · 16 Jul 2026 · 7 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
What would change my mind about repair peptides: a specific answer Replied, post #24 · Compounds › Repair & healing peptides · 14 Jul 2026 · 5 likes On post #20 — agreed on the reasoning, with one qualification. TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #39 · Practice › Reconstitution · 11 Jul 2026 · 4 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #53 · Access › Insurance & coverage · 4 Jul 2026 · 25 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #24 · Nutrition & Training › Protein & intake · 2 Jul 2026 · 4 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
-
Why the timeline is on the right and not the left — what changed since Replied, post #60 · Meta › Site feedback · 23 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #51 · Evidence › Journal club · 22 Jun 2026 · 5 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #125 · Access › Insurance & coverage · 20 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coming back to: A newcomer's list of things that confused me, and the fixes Replied, post #8 · Start Here › Welcome · 17 Jun 2026 · 14 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #35 · Compounds › Oral incretins · 10 Jun 2026 · 17 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #24 · Practice › Side effects · 8 Jun 2026 · 23 likes Picking up post #21: that is the part I would want checked first. Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #24 · Research Methods › N-of-1 designs · 4 Jun 2026 · 2 likes Worth separating two things that post #20 runs together. When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether…
-
Review: an evidence digest and the citation check that delayed it Replied, post #8 · Documentation › Doc review · 26 May 2026 · 11 likes Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says. If you notice a mismatch, post it here.
-
Revisiting: The best-written scientific paper you have read Replied, post #4 · Lounge › Off topic · 26 May 2026 · 0 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #79 · Outcomes › Body composition · 19 May 2026 · 0 likes Coming back to post #77, because the follow-up matters more than the original answer. DXA (dual-energy X-ray absorptiometry): the standard for body composition in…
-
Reading a home test result without over-claiming Replied, post #31 · Analytics › Home & field testing · 4 May 2026 · 11 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #102 · Sourcing › Vendor reports · 2 May 2026 · 8 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #7 · Practice › Reconstitution · 17 Apr 2026 · 13 likes Coming back to post #5, because the follow-up matters more than the original answer. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL…
-
Journal club: is percentage weight change the right endpoint? Replied, post #41 · Evidence › Journal club · 5 Apr 2026 · 4 likes I read post #39 twice before replying, because I had assumed the opposite. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design…
-
Prediction intervals and why they are more honest than confidence intervals Replied, post #4 · Evidence › Meta-analyses · 1 Apr 2026 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #119 · Research Methods › N-of-1 designs · 30 Mar 2026 · 5 likes post #118 is right about the mechanism and I think understates the practical bit. Statistical analysis of n-of-1 data: comparing before versus after with a t-test or…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #49 · Evidence › Trials · 30 Mar 2026 · 24 likes This follows post #46 rather than contradicting it. Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a…
-
Injection volume, overload, and peak distortion — one year on Replied, post #8 · Analytics › HPLC & UHPLC · 25 Mar 2026 · 0 likes Picking up post #5: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #81 · Analytics › Mass spectrometry · 24 Mar 2026 · 26 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #9 · Sourcing › Independent verification · 20 Mar 2026 · 2 likes post #8 answers the question as asked. The question underneath it is different. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #84 · Practice › Storage & stability · 20 Mar 2026 · 20 likes This follows post #81 rather than contradicting it. I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is…
-
GLP-1 receptor distribution: central and peripheral Replied, post #16 · Pharmacology › Receptor biology · 15 Mar 2026 · 2 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
Revisiting: Maintainer handover: how it works Replied, post #54 · Meta › Wiki maintenance · 15 Mar 2026 · 6 likes Scope creep: if a page is attempting too much, suggesting it split into multiple pages can improve clarity.
-
When a dose reduction is the correct response to a side effect Replied, post #3 · Practice › Dosing & titration · 2 Mar 2026 · 13 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Measurement error in a self-reported exposure Replied, post #95 · Evidence › Study critique · 26 Feb 2026 · 7 likes Coming back to post #93, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Designing a personal experiment that could change your mind — one year on Replied, post #14 · Research Methods › N-of-1 designs · 23 Feb 2026 · 0 likes Worth separating two things that post #10 runs together. Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1…
-
Absence of evidence and evidence of absence Replied, post #16 · Research Methods › Statistics · 5 Feb 2026 · 22 likes Worth separating two things that post #12 runs together. Relative risk and odds ratios: both compare the rate in one group to the rate in another. Relative risk is…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #61 · Practice › Storage & stability · 4 Feb 2026 · 0 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #15 · Evidence › Study critique · 30 Jan 2026 · 4 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #45 · Practice › Dosing & titration · 20 Jan 2026 · 6 likes Worth separating two things that post #41 runs together. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #38 · Sourcing › Independent verification · 10 Dec 2025 · 21 likes On post #34 — agreed on the reasoning, with one qualification. Repeat testing: if you want to verify the same lot a second time, testing with a different service…
-
The headache that turns out to be dehydration Replied, post #81 · Nutrition & Training › Hydration & electrolytes · 4 Dec 2025 · 13 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
-
[2026 update] What steady state means for the decision to escalate Replied, post #107 · Practice › Dosing & titration · 16 Nov 2025 · 8 likes post #106 is right about the mechanism and I think understates the practical bit. Dose equivalence between different incretin analogues is a weak concept. The molecules…
-
EMA product information as a primary source Replied, post #41 · Regional › European Union · 7 Nov 2025 · 4 likes post #40 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
A 40-week log with the measurement method stated Replied, post #98 · Outcomes › Progress reports · 30 Oct 2025 · 0 likes This follows post #95 rather than contradicting it. Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them…
-
Compounds this community declines to help with, and why Replied, post #3 · Compounds › Other compounds · 22 Sep 2025 · 7 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #39 · Practice › Dosing & titration · 9 Sep 2025 · 13 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #13 · Lounge › Off topic · 31 Aug 2025 · 3 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
Angle of injection and whether 90 degrees is always right Replied, post #16 · Practice › Administration · 30 Aug 2025 · 0 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Journal club: PIONEER 6 as a safety trial Replied, post #2 · Evidence › Journal club · 20 Aug 2025 · 9 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Started this topic · Research Methods › N-of-1 designs · 16 Aug 2025 · 22 likes The question in the title: Why most self-reports here are not experiments, and that is fine I will give what I have already checked below so nobody repeats it.…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #15 · Practice › Administration · 10 Aug 2025 · 17 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Washout: how long is long enough, and for what purpose Replied, post #53 · Pharmacology › Pharmacokinetics · 7 Aug 2025 · 6 likes post #52 is right about the mechanism and I think understates the practical bit. Fasting requirement for oral semaglutide: food and large fluid volumes reduce…
-
Comparing the STEP programme populations: who was actually enrolled — the long version Replied, post #2 · Compounds › Semaglutide · 15 Jul 2025 · 0 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
A comparison of home results against a laboratory result on the same vial Replied, post #13 · Analytics › Home & field testing · 11 Jul 2025 · 12 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #81 · Practice › Reconstitution · 4 Jul 2025 · 1 like Worth separating two things that post #77 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #19 · Compounds › Semaglutide · 27 Jun 2025 · 8 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #24 · Analytics › HPLC & UHPLC · 25 Jun 2025 · 0 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
About the Tirzepatide category Replied, post #5 · Compounds › Tirzepatide · 25 Jun 2025 · 28 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Checking someone else's arithmetic: a worked example thread Replied, post #60 · Practice › Reconstitution · 23 Jun 2025 · 5 likes On post #56 — agreed on the reasoning, with one qualification. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #7 · Analytics › HPLC & UHPLC · 14 Jun 2025 · 0 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #110 · Data & Tools › Calculators · 3 Jun 2025 · 15 likes post #109 answers the question as asked. The question underneath it is different. Reporting bugs: if you notice a calculator giving wrong results, report it in this…
-
Reading a supplier's product description as a marketing document Replied, post #29 · Compounds › Other compounds · 3 Jun 2025 · 13 likes post #28 answers the question as asked. The question underneath it is different. Distinguishing marketed research compounds from true chemical synthesis: some online…
-
Residual solvents and scavengers: what is looked for Replied, post #20 · Analytics › Impurities & related substances · 5 May 2025 · 19 likes post #19 is right about the mechanism and I think understates the practical bit. Deletion sequences (incomplete coupling during synthesis): lower in mass by one…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #8 · Analytics › Home & field testing · 20 Apr 2025 · 0 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #92 · Documentation › Doc review · 6 Apr 2025 · 8 likes On post #88 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
A promotion I argued against, and why I lost Replied, post #157 · Documentation › Doc review · 2 Apr 2025 · 9 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
Reading order for a first week here, and what to skip until later Replied, post #53 · Start Here › Welcome · 26 Mar 2025 · 32 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Charge states for a 4 kDa peptide, worked through Replied, post #36 · Analytics › Mass spectrometry · 6 Mar 2025 · 0 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Fibre intake when total intake falls, and the constipation link Replied, post #28 · Nutrition & Training › Protein & intake · 13 Feb 2025 · 0 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #13 · Regional › UK & Ireland · 29 Jan 2025 · 3 likes Picking up post #10: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Second pass at: Regression to the mean in progress reports Replied, post #18 · Research Methods › Statistics · 7 Jan 2025 · 1 like I read post #16 twice before replying, because I had assumed the opposite. Effect sizes: the magnitude of a difference, not just whether it is statistically…
-
What changed in 2026, by region Replied, post #51 · Access › International · 1 Jan 2025 · 0 likes Coming back to post #49, because the follow-up matters more than the original answer. Travel with medication: carrying a compound across borders is complicated by legal…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #25 · Compounds › Oral incretins · 25 Dec 2024 · 12 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #12 · Devices › Syringes & needles · 24 Dec 2024 · 25 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #54 · Evidence › Trials · 23 Dec 2024 · 4 likes post #53 is right about the mechanism and I think understates the practical bit. Dropout is information: high dropout rates can indicate tolerability problems or lower…
-
[2026 update] New subcategory: rationale and scope Replied, post #69 · Meta › Announcements · 16 Dec 2024 · 32 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
Converting between mg/mL and units per dose, both directions Replied, post #81 · Practice › Reconstitution · 8 Nov 2024 · 25 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #10 · Clinical › Special populations · 6 Nov 2024 · 17 likes Coming back to post #8, because the follow-up matters more than the original answer. Pregnancy and planning: these compounds are not approved for use in pregnancy.…
-
US compounding rules and how they changed Replied, post #47 · Regional › North America · 30 Oct 2024 · 18 likes Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both countries' import rules. The medication is legal but crossing borders with it…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #91 · Clinical › Comorbidities · 24 Oct 2024 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Converting between mg/mL and units per dose, both directions Replied, post #62 · Practice › Reconstitution · 24 Oct 2024 · 0 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Turnaround times and what they mean for a decision — one year on Replied, post #7 · Sourcing › Independent verification · 14 Oct 2024 · 7 likes post #6 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #3 · Compounds › Other compounds · 13 Oct 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Requesting a page: what makes a good request — what changed since Replied, post #110 · Documentation › Wiki requests · 12 Oct 2024 · 0 likes post #109 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Started this topic · Practice › Dosing & titration · 11 Oct 2024 · 35 likes The question in the title: Revisiting: Holding a dose indefinitely: is there a documented downside? I will give what I have already checked below so nobody repeats it.…
-
Why a preprint's supplementary material is often the best part Replied, post #4 · Evidence › Preprints · 26 Aug 2024 · 10 likes This follows post #2 rather than contradicting it. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #60 · Practice › Dosing & titration · 25 Jul 2024 · 7 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Journal club: FLOW and the renal composite, component by component Replied, post #45 · Evidence › Journal club · 13 Jul 2024 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…